Pegylated Interferon Alfa-2b Monotherapy and Pegylated Interferon Alfa-2b plus Lamivudine Combination Therapy for Patients with Hepatitis B Virus E Antigen-Negative Chronic Hepatitis B

Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of <400 copies/m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kaymakoglu, Sabahattin, Oguz, Dilek, Gur, Gurden, Gurel, Selim, Tankurt, Ethem, Ersöz, Galip, Ozenirler, Seren, Kalayci, Cem, Poturoglu, Sule, Cakaloglu, Yılmaz, Okten, Atilla
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2007
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1932537/
https://ncbi.nlm.nih.gov/pubmed/17517832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00088-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados